HK Stocks Movement | HighTide Therapeutics-B (02511.HK) Rises Over 5% as T2DM Indication Nears Commercialization; HTD1801 Clinical Data Presented at Multiple International Conferences
Zhito Finance APP has learned that HighTide Therapeutics-B (02511.HK) rose more than 5%, up 5.44% as of press time, at HK$3.295, with a turnover of HK$12.6095 million.
Latest
2 m ago
